Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has an Asset Resilience Ratio of 0.20% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's Asset Resilience Ratio has changed over time. Check RIG2 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Richter Gedeon Vegyészeti Gyár Nyilvános worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.14 Billion | 0.2% |
| Total Liquid Assets | €3.14 Billion | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Industry Peers by Asset Resilience Ratio
Compare Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 48.48% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 15.57% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
Annual Asset Resilience Ratio for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.73% | €46.34 Billion ≈ $54.18 Billion |
€1.70 Trillion ≈ $1.99 Trillion |
+2.67pp |
| 2024-12-31 | 0.06% | €994.00 Million ≈ $1.16 Billion |
€1.61 Trillion ≈ $1.88 Trillion |
-0.50pp |
| 2023-12-31 | 0.57% | €7.69 Billion ≈ $8.99 Billion |
€1.36 Trillion ≈ $1.59 Trillion |
-2.89pp |
| 2022-12-31 | 3.45% | €46.25 Billion ≈ $54.07 Billion |
€1.34 Trillion ≈ $1.57 Trillion |
+3.37pp |
| 2021-12-31 | 0.08% | €912.00 Million ≈ $1.07 Billion |
€1.15 Trillion ≈ $1.34 Trillion |
-0.67pp |
| 2020-12-31 | 0.75% | €7.14 Billion ≈ $8.35 Billion |
€948.59 Billion ≈ $1.11 Trillion |
+0.57pp |
| 2019-12-31 | 0.18% | €1.54 Billion ≈ $1.81 Billion |
€858.65 Billion ≈ $1.00 Trillion |
-0.41pp |
| 2018-12-31 | 0.59% | €4.73 Billion ≈ $5.53 Billion |
€797.88 Billion ≈ $932.81 Billion |
+0.59pp |
| 2017-12-31 | 0.00% | €18.00 Million ≈ $21.04 Million |
€760.87 Billion ≈ $889.53 Billion |
-0.09pp |
| 2016-12-31 | 0.09% | €751.00 Million ≈ $878.00 Million |
€813.88 Billion ≈ $951.51 Billion |
-0.44pp |
| 2015-12-31 | 0.53% | €3.97 Billion ≈ $4.64 Billion |
€746.99 Billion ≈ $873.31 Billion |
-2.37pp |
| 2014-12-31 | 2.90% | €20.87 Billion ≈ $24.40 Billion |
€720.06 Billion ≈ $841.82 Billion |
+2.36pp |
| 2013-12-31 | 0.53% | €3.82 Billion ≈ $4.46 Billion |
€714.14 Billion ≈ $834.91 Billion |
-- |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more